OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging Strategies in TCR-Engineered T Cells
Wei Fang, Xiao-Xia Cheng, John Z. Xue, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Wei Fang, Xiao-Xia Cheng, John Z. Xue, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer
Jia Han, B. Zhang, Senyu Zheng, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 16
Jia Han, B. Zhang, Senyu Zheng, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 16
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Current trends of clinical trials involving CRISPR/Cas systems
Song‐Yang Zhang, Yidi Wang, Dezhi Mao, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 20
Song‐Yang Zhang, Yidi Wang, Dezhi Mao, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 20
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
Jessica S.W. Borgers, Divya Lenkala, Victoria Kohler, et al.
Nature Medicine (2025)
Open Access
Jessica S.W. Borgers, Divya Lenkala, Victoria Kohler, et al.
Nature Medicine (2025)
Open Access
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma
Kamil Synoradzki, Natalia Paduszyńska, Małgorzata Solnik, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 778-800
Open Access | Times Cited: 4
Kamil Synoradzki, Natalia Paduszyńska, Małgorzata Solnik, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 778-800
Open Access | Times Cited: 4
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Meng–Yao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Meng–Yao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Advanced Immunomodulatory Biomaterials for Therapeutic Applications
Ji‐Eun Park, Dong‐Hwee Kim
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 4
Ji‐Eun Park, Dong‐Hwee Kim
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 4
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer
L. Mazzotti, Anna Gaimari, Sara Bravaccini, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8590-8590
Open Access | Times Cited: 24
L. Mazzotti, Anna Gaimari, Sara Bravaccini, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8590-8590
Open Access | Times Cited: 24
Challenges and solutions for therapeuticTCR ‐based agents
Manish Malviya, Zita E. H. Aretz, Zaki Molvi, et al.
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 58-82
Closed Access | Times Cited: 14
Manish Malviya, Zita E. H. Aretz, Zaki Molvi, et al.
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 58-82
Closed Access | Times Cited: 14
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 14
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 14
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions
Thomas Böldicke
Antibodies (2022) Vol. 11, Iss. 3, pp. 49-49
Open Access | Times Cited: 15
Thomas Böldicke
Antibodies (2022) Vol. 11, Iss. 3, pp. 49-49
Open Access | Times Cited: 15
HDAC6 inhibition releases HR23B to activate proteasomes, expand the tumor immunopeptidome and amplify T-cell antimyeloma activity
Priyanka S. Rana, James J. Ignatz-Hoover, Byung‐Gyu Kim, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 6, pp. 1517-1532
Open Access | Times Cited: 2
Priyanka S. Rana, James J. Ignatz-Hoover, Byung‐Gyu Kim, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 6, pp. 1517-1532
Open Access | Times Cited: 2
Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors
Katerina Kalkusova, Sindija Smite, Elea Darras, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11080-11080
Open Access | Times Cited: 12
Katerina Kalkusova, Sindija Smite, Elea Darras, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11080-11080
Open Access | Times Cited: 12
Epigenetic and Genetic Keys to Fight HPV-Related Cancers
Veronica Folliero, Federica Dell’Annunziata, Annalisa Chianese, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5583-5583
Open Access | Times Cited: 6
Veronica Folliero, Federica Dell’Annunziata, Annalisa Chianese, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5583-5583
Open Access | Times Cited: 6
Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”
Karin Teppert, Xueting Wang, Kathleen Anders, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14563-14563
Open Access | Times Cited: 10
Karin Teppert, Xueting Wang, Kathleen Anders, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14563-14563
Open Access | Times Cited: 10
Advances in adoptive cellular therapy for colorectal cancer: a narrative review
Xing Yi, Wenwei Hu
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1404-1404
Open Access | Times Cited: 10
Xing Yi, Wenwei Hu
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1404-1404
Open Access | Times Cited: 10
Specificity and function of T cell subset identities using single‐cell sequencing
Xuanqi Liu, Zhenhua Zhu, Xiangdong Wang
Clinical and Translational Discovery (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 5
Xuanqi Liu, Zhenhua Zhu, Xiangdong Wang
Clinical and Translational Discovery (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 5
Targeted Therapy of Multiple Sclerosis: a Case for Antigen-specific Tregs
Hans J. Stauss, Yiya Zhong
(2024)
Open Access | Times Cited: 1
Hans J. Stauss, Yiya Zhong
(2024)
Open Access | Times Cited: 1
Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies
Laura H. Porter, Sophie Harrison, Gail P. Risbridger, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 243, pp. 106571-106571
Open Access | Times Cited: 1
Laura H. Porter, Sophie Harrison, Gail P. Risbridger, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 243, pp. 106571-106571
Open Access | Times Cited: 1
Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential
Diego F. Chamorro, Lauren K. Somes, Valentina Hoyos
Cancers (2023) Vol. 16, Iss. 1, pp. 124-124
Open Access | Times Cited: 4
Diego F. Chamorro, Lauren K. Somes, Valentina Hoyos
Cancers (2023) Vol. 16, Iss. 1, pp. 124-124
Open Access | Times Cited: 4
T Cell Receptor Chain Centricity: The Phenomenon and Potential Applications in Cancer Immunotherapy
A. A. Kalinina, Л. М. Хромых, D. B. Kazansky
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15211-15211
Open Access | Times Cited: 3
A. A. Kalinina, Л. М. Хромых, D. B. Kazansky
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15211-15211
Open Access | Times Cited: 3
A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments
Rosario Hervás-Salcedo, Beatriz Martín-Antonio
Cancers (2022) Vol. 14, Iss. 15, pp. 3796-3796
Open Access | Times Cited: 6
Rosario Hervás-Salcedo, Beatriz Martín-Antonio
Cancers (2022) Vol. 14, Iss. 15, pp. 3796-3796
Open Access | Times Cited: 6
Biological Biomarkers of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma
Claire Masson, Jonathan Thouvenin, Philippe Boudier, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3159-3159
Open Access | Times Cited: 2
Claire Masson, Jonathan Thouvenin, Philippe Boudier, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3159-3159
Open Access | Times Cited: 2
Evolution by innovation as a driving force to improve TCR-T therapies
Dolores J. Schendel
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Dolores J. Schendel
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
The Expression of LDL-R in CD8+T Cells Serves as an Early Assessment Parameter for the Production of TCR-T Cells
Yi Wang, Yanan Hao, Meiying Shen, et al.
In Vivo (2023) Vol. 37, Iss. 6, pp. 2480-2489
Open Access | Times Cited: 2
Yi Wang, Yanan Hao, Meiying Shen, et al.
In Vivo (2023) Vol. 37, Iss. 6, pp. 2480-2489
Open Access | Times Cited: 2
